Tag: Biotech
The oligonucleotide synthesis, modification and purification services market -Roots Analysis
The applications of oligonucleotides are vast, even beyond the life science / pharma sector; however, owing to complexities associated with the synthesis and processing of these molecules, such operations are usually outsourced to capable CMOs
The ophthalmic drugs contract manufacturing market - Roots Analysis
Outsourcing has become a popular trend among ophthalmic drug developers, allowing them to leverage the expertise / larger production capacities of CMOs / CDMOs and achieve significant cost and time related advantages
The patient recruitment and retention services market RootsAnalysis
A steadily increasing demand for participants in clinical research studies, coupled to the complexities associated with patient enrolment, have prompted drug / therapy developers to outsource this process to specialty service providers
The HPAPI and cytotoxic drugs contract manufacturing market - Roots Analysis
Manufacturing highly potent drug products is technically and financially demanding; as a result, drug manufacturers are becoming increasingly reliant on contract service providers
The continuous manufacturing market – Roots Analysis
The report features an extensive study of the current market landscape and future opportunities for companies with capabilities in continuous manufacturing (both innovator companies with in-house expertise and contract manufacturers). It features an in-de...
The Designated Protein Degradation Market, 2020-2030
? A detailed assessment of the current market landscape of targeted protein degradation-based therapeutics, providing information on drug / therapy developer(s) (such as year of establishment, company size and location of headquarters
Subcutaneous Biologics- Roots Analysis
Several approved therapeutic products, which are currently available as intravenous dosage forms, are being reformulated and evaluated for subcutaneous administration. Further, many existing drug delivery devices, including prefilled syringes, pen injecto...
The ophthalmic drugs contract manufacturing market
Outsourcing has become a popular trend among ophthalmic drug developers, allowing them to leverage the expertise / larger production capacities of CMOs / CDMOs and achieve significant cost and time related advantages
The squamous non-small cell lung cancer market is projected to grow at a CAGR of 10.8% till 2030, claims Roots Analysis
Roots Analysis has announced the addition of “Squamous Non-small Cell Lung Cancer Market, 2021-2031” report to its list of offerings.
The light activated therapies market is anticipated to grow at an annualized rate of 27.7% till 2030, claims Roots Analysis
Roots Analysis has announced the addition of “Light Activated Therapies Market: Focus on Photodynamic Therapies, Photoimmunotherapies and Photothermal, 2021-2030“ report to its list of offerings.
Comprehensive Study on Bursitis Treatment Market 2021-2028: Business Opportunity and Recent Development Analysis by J&J, Carl Zeiss, Allergan, Topcon, Biotech
The Global Bursitis Treatment Market is expected to gain market growth at a potential rate of 5.80% in the forecast period of 2021 to 2028.
The targeted protein degradation market is projected to grow at an annualized
? More than 85 small molecule protein degraders are currently being evaluated for the treatment of various disease indications; in addition, there are 25+ technology platforms available for use in therapy development efforts
The synthetic lethality-based drugs and targets market is estimated to be worth
Advances in molecular screening technology have enabled the identification of novel synthetic lethal gene combinations, enabling the development of lead candidates that leverage the aforementioned phenomenon to offer therapeutic benefit.
The STING pathway targeting technologies market, featuring a healthy
STING, having generated significant interest within the medical research community, is currently considered one of the fastest growing areas of cancer immunotherapy and is being pursued by several large pharmaceutical companies
Presently, more than 120 companies claim to offer AR / VR and affiliated digital marketing services to the global healthcare industry, claims Roots Analysis
Over time, various pharma players have taken advantage of these immersive technologies for education, training as well as marketing, purposes. These technologies have been demonstrated to be capable of driving better customer engagement
